ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1153

Colonic Intraepithelial Lymphocytes Produce IL-6 in Response to Resident Bacteria to Modulate Epithelial Barrier Function

Gaurav Mehta1, Emilie H. Regner2, Neha Ohri2, Sean P. Colgan2 and Kristine A. Kuhn2, 1Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 2University of Colorado School of Medicine, Aurora, CO

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: IL-6, microbiome, mucosal T cells and mucosal barriers

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  Dysbiosis of colon bacteria has emerged as a likely contributor to diseases such as rheumatoid arthritis and spondyloarthropathies. Interactions between the microbiota and distal gut are critical for human health. These interactions are focused at the level of the colonic mucosa, and intestinal epithelial homeostasis is regulated by multiple signals emanating from both microbes and immune cells. As intraepithelial lymphocytes (IELs) are positioned within the epithelial barrier, we hypothesized that colon bacteria can modulate epithelial barrier function through interactions with IELs. 

Methods:  Epithelial cells were harvested from wild type C57Bl/6 mice, and lymphocytes evaluated by flow cytometry for T cell surface markers or magnetically sorted and stimulated ex vivo with mitogen for evaluation of cytokine production by ELISA. To model dysbiosis, mice were treated with ampicillin, metronidazole, neomycin, and vancomycin in the drinking water. Recolonization of mice occurred by cohousing antibiotic treated mice with unmanipulated littermates. Epithelial barrier integrity was evaluated by paracellular permeability of indigestible FITC-dextran in vivo and in vitro using the model human colonic cell line T84. Contact of host bacteria with the epithelium was performed by FISH using a universal bacterial probe. Protein and RNA analyses were done by Western blot and qRT-PCR, respectively.

Results: Our data demonstrate the major subpopulation of IELs in the mouse colon are CD3+, CD4-CD8-, and TCRβ+, express cell surface markers consistent with activated lymphocytes, and produce large amounts of IL-6 under mitogenic stimulation. Administration of significantly decreased the number of activated, IL-6-secreting IELs. This was reversible, as recolonization resulted in normalization of the IEL numbers, IL-6 secretion, and epithelial barrier integrity. The epithelial barrier in IL-6-/- and antibiotic-treated mice was noted to have increased paracellular permeability and closer interaction with luminal bacteria. IL-6 was found to signal in colonic epithelial cells and resulted in increased epithelial barrier integrity and claudin 1 expression in model epithelia. 

Conclusion:  We conclude that the host microbiota provides a homeostatic role through regulation of IEL derived IL-6. In turn, IL-6 participates in a barrier protective role in which it stimulates increased tight junction protein expression and decreased contact between luminal bacteria and the host. We postulate that dysbiosis, through the loss of IEL-derived IL-6, in combination with genetic risk, results in increased immune activation at the mucosal barrier, leading to downstream autoimmune responses.


Disclosure: G. Mehta, None; E. H. Regner, None; N. Ohri, None; S. P. Colgan, None; K. A. Kuhn, None.

To cite this abstract in AMA style:

Mehta G, Regner EH, Ohri N, Colgan SP, Kuhn KA. Colonic Intraepithelial Lymphocytes Produce IL-6 in Response to Resident Bacteria to Modulate Epithelial Barrier Function [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/colonic-intraepithelial-lymphocytes-produce-il-6-in-response-to-resident-bacteria-to-modulate-epithelial-barrier-function/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/colonic-intraepithelial-lymphocytes-produce-il-6-in-response-to-resident-bacteria-to-modulate-epithelial-barrier-function/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology